Same medicine. Same results.
Lower cost.
  • Biosimilars


    GPhA applauds Congress for establishing an abbreviated...
  • Drug Shortages

    As members of the public who also are affected by...
  • Quality

    Science and quality are the cornerstones of the generic...
  • Patent Settlements

    Patent Settlements

    GPhA vigorously opposes restricting the right of parties in...

    GPhA and its member companies support full implementation...

Improving Lives for Less

*New data* The 2014 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system and patients $239 billion in 2013. That’s $1.46 trillion dollars in the most recent decade. This year's report discusses annual savings, 10-year savings and a breakdown by therapy area. All data were compiled by IMS Health on behalf of GPhA.   learn more >

Value and Quality

2014 GPhA Annual Report

For GPhA and our member companies, 2014 was a year of significant milestones and outstanding achievements.

Click here to view the 2014 Annual Report.